Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.
View Top Employees from Eligo BioscienceWebsite | http://www.eligo-bioscience.com |
Revenue | $10 million |
Funding | $20 million |
Employees | 49 (49 on RocketReach) |
Founded | 2014 |
Address | 29 Rue Du Faubourg Saint-jacques, Paris, Ile de France 75014, FR |
Industry | Biotechnology Research, Business Services General, Business Services |
Competitors | Artios, Locus Biosciences, Inc., Pharming Group N.V., Second Genome Inc., Synthorx Inc |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Eligo Bioscience employee's phone or email?
The Eligo Bioscience annual revenue was $10 million in 2024.
Jesus Fernandez Rodriguez is the Vice President Technology of Eligo Bioscience.
49 people are employed at Eligo Bioscience.
Eligo Bioscience is based in Paris, Ile de France.
The NAICS codes for Eligo Bioscience are [541713, 54171, 5417, 54, 541].
The SIC codes for Eligo Bioscience are [873, 87].